Skip to main content

Advertisement

SpringerLink
Log in

Irreversible Electroporation: a Novel Option for Treatment of Hepatic Metastases

  • Colorectal Cancer Hepatic Metastases (KK Tanabe, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Irreversible electroporation (IRE) has shown promise for ablation of lesions in proximity to vital structures in the preclinical and now clinical setting. Studies of patients undergoing IRE for treatment of metastatic colorectal cancer to the liver were reviewed for patient and tumor characteristics, treatment-related complications, and local recurrence-free survival (LRFS) for ablated lesions. LRFS was calculated according to the Kaplan–Meier method, with secondary analyses stratified by procedural approach (laparotomy, laparoscopy, percutaneous) and tumor histological characteristics. Initial IRE success has been achieved in 95 % of treatments. The LRFS rates at 3, 6, and 12 months were 97.4 %, 94.6 %, and 59.5 %. There was a trend toward higher recurrence rates for tumors larger than 4 cm (hazard ratio 3.236, 95 % confidence interval 0.585-17.891; p = 0.178). IRE is a safe and effective treatment for metastatic colorectal cancer to the liver near vital structures. Continued evaluation is needed to determine optimal probe design and techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–24.

    Article  PubMed  Google Scholar 

  2. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685.

    PubMed  Google Scholar 

  3. Sindram D, Lau KN, Martinie JB, Iannitti DA. Hepatic tumor ablation. Surg Clin North Am. 2010;90:863–76.

    Article  PubMed  Google Scholar 

  4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655–61.

    PubMed  CAS  Google Scholar 

  5. Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer. 1991;68:1524–30.

    Article  PubMed  CAS  Google Scholar 

  6. Vogl TJ, Mack MG, Muller PK, Straub R, Engelmann K, Eichler K. Interventional MR: interstitial therapy. Eur Radiol. 1999;9:1479–87.

    Article  PubMed  CAS  Google Scholar 

  7. Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J Gastroenterol Hepatol. 2001;16:548–52.

    Article  PubMed  CAS  Google Scholar 

  8. Vogl TJ, Eichler K, Straub R, Engelmann K, Zangos S, Woitaschek D, et al. Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s) – side effects, complications and results. Eur J Ultrasound. 2001;13:117–27.

    Article  PubMed  CAS  Google Scholar 

  9. Ravikumar TS, Steele Jr GD. Hepatic cryosurgery. Surg Clin North Am. 1989;69:433–40.

    PubMed  CAS  Google Scholar 

  10. Shen HP, Gong JP, Zuo GQ. Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg. 2011;77:1496–501.

    PubMed  Google Scholar 

  11. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89:276–84.

    Article  PubMed  CAS  Google Scholar 

  12. Yu NC, Lu DS, Raman SS, Dupuy DE, Simon CJ, Lassman C, et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters–pilot comparison with pathologic findings. Radiology. 2006;239:269–75.

    Article  PubMed  Google Scholar 

  13. • O'Connor JK, Trotter J, Davis GL, Dempster J, Klintmalm GB, Goldstein RM. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl. 2012;18:949–54. This is one of the largest studies to report on stereotactic (intensity-modulated) radiation therapy, similar to CyberKnife therapy in the case of hepatic tumors.

    Article  PubMed  Google Scholar 

  14. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054–60.

    Article  PubMed  Google Scholar 

  15. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253–62.

    Article  PubMed  Google Scholar 

  16. Kim SW, Rhim H, Park M, Kim H, Kim YS, Choi D, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10:366–76.

    Article  PubMed  Google Scholar 

  17. Lim DH, Lee H, Park HC, Lee JA, Kim SW, Yoo BC, et al. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities. Am J Clin Oncol. 2012;1024:1024. doi:10.1097/COC.0b013e3182438dae.

    Google Scholar 

  18. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, et al. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol. 2006;29:562–7.

    Article  PubMed  Google Scholar 

  19. Lee RC. Cell injury by electric forces. Ann N Y Acad Sci. 2005;1066:85–91.

    Article  PubMed  CAS  Google Scholar 

  20. • Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104:22–8. This is the first report to demonstrate the safety of the use of IRE around vital blood vessels.

    Article  PubMed  Google Scholar 

  21. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6:307–12.

    PubMed  Google Scholar 

  22. • Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 2010;70:1555–63. This article is an additional report on the safety of IRE in the liver in an in vivo model.

    Article  PubMed  CAS  Google Scholar 

  23. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the liver and liver hilum in swine. HPB. 2011;13:168–73.

    PubMed  Google Scholar 

  24. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB. 2010;12:348–51.

    PubMed  Google Scholar 

  25. Martin 2nd RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215:361–9.

    Article  PubMed  Google Scholar 

  26. Martin 2nd RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2012;2424:2424. doi:10.1245/s10434-012-2736-1.

    Google Scholar 

  27. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  PubMed  CAS  Google Scholar 

  28. Niessen C, Jung EM, Stroszczynski C, Wiggermann P. Ablation einer Lebermetastase mit irreversibler Elektroporation (IRE) im Lebersegment II angrenzend an die Area nuda [Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda]. Rofo. 2012;184:937–8.

    Article  PubMed  CAS  Google Scholar 

  29. • Cannon R, Ellis S, Hayes D, Narayanan G, Martin 2nd RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2012;2424:2424. doi:10.1002/jso.23280. This is the largest study of the use of IRE for ablation of hepatic tumors close to vital structures with long-term 12-month follow-up.

    PubMed  Google Scholar 

  30. Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22:611–21.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

Robert C.G. Martin II has received compensation from AngioDynamics for serving as a consultant.

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Surgical Oncology, University of Louisville, 315 East Broadway, Suite 314, Louisville, KY, 40202, USA

    Robert C. G. Martin II

Authors
  1. Robert C. G. Martin II
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert C. G. Martin II.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martin, R.C.G. Irreversible Electroporation: a Novel Option for Treatment of Hepatic Metastases. Curr Colorectal Cancer Rep 9, 191–197 (2013). https://doi.org/10.1007/s11888-013-0166-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-013-0166-5

Keywords

Search

Navigation